InsidersTradesSigma
Track the 셀바이오휴먼텍 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Food & Beverage sector, 셀바이오휴먼텍 has published 42 public disclosures. Market capitalisation: €50.8bn. The latest transaction was filed on 12 June 2026 (Purchase). Among the most active insiders: 이권선. The full history is accessible without an account.
42
Insider Decl.
n/a
Thresholds
n/a
41 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,185 of 29,057 companies
66.0
score / 100
Value65
Quality67
FCF yld-9.6%
Earn yld16%
EV/EBITDA6.5x
ROE17%
Gross mgn37%
Net mgn17%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 June 2026
Declarations42 total
25 of 42 declarations
About 셀바이오휴먼텍
Selbio Human Tech is a company operating in the food sector, listed on the XKRX market. It specializes in developing innovative solutions for the food industry.